SAM #75D301-26-Q-98063

CDC Sole Source Procurement: TSI MOUDI-II Impactor for Inhalation Research

This CDC procurement opportunity is for a sole-source purchase of TSI MOUDI-II impactors for inhalation research, with detailed requirements and specifications provided. - Agency: Centers for Disease Control and Prevention (CDC), Office of Acquisition Services; National Institute for Occupational Safety and Health (NIOSH) - Sole-source intent: TSI Incorporated is identified as the only vendor capable of meeting technical requirements - Equipment requested: - MOUDI-II Impactor, 10 Stage (Model 120R) - Nano-MOUDI-II Impactor, 13 Stage (Model 125R) - Vacuum pumps for both models (110V and 220V) - Sample collection substrates: aluminum foil, glass fiber, quartz fiber filters - Accessories: silicone impactor surface spray, lubricating grease - Specific procurement for NIOSH includes: - One MOUDI-II, 10 stage impactor (particle size range: 0.05 to 18 micrometers) - Shipping to NIOSH Morgantown laboratory - Technical requirements: - Wide size classification, uniform sample deposition, stepper motor stage rotation, micro-orifice nozzles, remote Ethernet control - CDC is accepting capability statements from other vendors, but TSI is considered the only source - Period of performance: June 1, 2026 – May 31, 2027; delivery by June 1, 2026 - No competing OEMs or products are specifically listed, but similar aerosol impactors may exist - Estimated contract value likely ranges from $20,000 to $60,000 based on instrument and accessories - Attachments provide detailed product line items and technical specifications

Description

This is a notice of intent to award a sole-source contract using simplified acquisition procedures and is not a request for competitive quotes.

The Centers for Disease Control and Prevention (CDC) intends to award a sole-source purchase order using the procedures at RFO 12.102(a) as it has been deemed that only one source is available to meet this specific requirement due to the intended vendor, TSI Incorporated being the only company making a Micro Orifice Uniform-Deposit Impactors (MOUDI) that meets the wide range of size classification, and the ability to deposit the samples uniformly for inhalation research. The statement of work and specifications are attached.

This notice of intent is not a request for competitive quotations. Any party who believes they can perform this requirement should submit a capability statement for consideration by the government. A determination by the government not to compete this proposed contract based on responses to this notice is solely within the discretion of the government. Information received by the government as a result of this notice will be considered solely for the purpose of determining whether to conduct competitive procurement.

The government will not be responsible for any costs incurred by a party who responds to this notice. A party may identify their interest and submit a capability statement by 4pm (EST) on 17 June 2026.

Responses, including questions about this notice, should be sent via email to Contract Specialist, Aminah Gary at uuu0@cdc.gov

View original listing